Crinetics Pharmaceuticals - 53 Year Dividend History | CRNX
Historical dividend payout and yield for Crinetics Pharmaceuticals (CRNX) since 1971. The current TTM dividend payout for Crinetics Pharmaceuticals (CRNX) as of November 20, 2024 is $0.00. The current dividend yield for Crinetics Pharmaceuticals as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$5.116B |
$0.004B |
|
Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
